Natural anti-Gal antibody as a universal augmenter of autologous tumor vaccine immunogenicity.
Galili
U
U
Dept of Microbiology and Immunology, MCP Hahnemann School of Medicine, Allegheny University of the Health Sciences, Philadelphia, PA 19129, USA. Galili@allegheny.edu
LaTemple
D C
DC
D000818:Animals; D000906:Antibodies / Q000627:therapeutic use*; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000276:immunology; D019496:Cancer Vaccines / Q000276:immunology*; D002240:Carbohydrate Sequence; D006801:Humans; D007113:Immunity, Innate; D008969:Molecular Sequence Data; D014312:Trisaccharides / Q000276:immunology*
D000906:Antibodies; D015295:Antigens, Tumor-Associated, Carbohydrate; D019496:Cancer Vaccines; D014312:Trisaccharides; C076569:alpha-galactosyl epitope